Menu Philippe 4
4 · SOPHiA GENETICS SA · Filed Jul 14, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 5,000 Shares
What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares on 2026-07-13 in an open-market/private sale. The reported weighted-average price was $5.70 per share, for total proceeds of $28,505. This was a sale (commonly routine) and was executed pursuant to a pre-established Rule 10b5-1 trading plan.
Key Details
- Transaction date: 2026-07-13; filing dated 2026-07-14 (timely).
- Price: weighted average $5.70; transaction prices ranged from $5.55 to $5.79 (footnote).
- Shares sold: 5,000; proceeds: $28,505.
- Shares owned after the transaction: not disclosed in this Form 4.
- Notable footnotes: sale made under a duly adopted 10b5-1(c) plan; weighted-average price reported with offer to provide a per-price breakdown on request.
- Filing timeliness: appears timely (no late-filing indication).
Context: Sales made under 10b5-1 plans are pre-scheduled and are often routine disposition transactions; this filing is factual and does not by itself indicate a change in insider sentiment.
Insider Transaction Report
Form 4
Menu Philippe
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-07-13$5.70/sh−5,000$28,505→ 228,387 total
Footnotes (2)
- [F1]Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.55 to $5.79, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Philippe Menu|2026-07-14